FDA OCET Project Report

Analysis of the Advantages of and Barriers to Adoption of Smart Manufacturing for Medical Products – Focus on Response to Emerging and Pandemic Threats

This project was completed on behalf of the FDA Office of Counterterrorism and Emerging Threats (OCET) under
FDA Award 75F40120P00303.

IAAE seeks to credential 10,000 learners globally, and to engage 10 of the top 20 companies in each regulated health industry, by the end of 2035.